Search results for "Atlas Copco "
Biomarkers give cancer patients better survival estimates
A method developed by UCLA scientists uses data about patients' genetic sequences to produce more reliable projections for survival time and how they might respond to possible treatments. The technique is an innovative way of using biomedical big data—which gleans patterns and trends from massive amounts of patient information—to achieve precision medicine—giving doctors the ability to better tailor their care for each individua...
Capturing measurements for European Wind Atlas programme
This summer the New European Wind Atlas (NEWA) programme will conduct a large measurement campaign in Sweden to minimise the uncertainties of wind field prediction in complex terrain.
Infineon sensor chips help CERN to detect dark matter
95% of the universe is still considered unexplored. Scientists at CERN, the world’s largest particle physics research centre, are working on solving these mysteries. In May 2012, researchers there discovered the so-called Higgs Boson, whose prediction won Peter Higgs and François Englert the Nobel prize in physics.
SCAMP robots fly, perch and climb
Roboticists are as focused on small robots that can function and go where the big robots cannot. It's all about scale at the Biomimetics and Dexterous Manipulation Laboratory at Stanford. They are working on robots that live at the boundary of airborne and surface locomotion. Smaller robots are robust in dealing with impacts, more capable of rapid orientation changes, and can achieve higher adhesive forces relative to their size.
UK in the driving seat of driverless cars
A UK initiative designed to study data critical to the efficient operation of driverless cars has secured funding from Innovate UK that will put the country at the forefront of connected and autonomous vehicles.The Atlas initiative, a consortium of UK businesses, will use the funding to research and develop communication between vehicles and roadside infrastructure.
Prototype of neurorobotics platform released
An important milestone for the Human Brain Project has been reached: as of 30th March, the prototypes of the six information and communications technology (ICT) platforms are set for release. The neurorobotics platform, led by the Technical University of Munich (TUM), gives scientists the chance to apply brain models to various different robots and thus conduct their own experiments.
Atlas is the latest (and quietest) humanoid robot
Boston Dynamics unveiled a new humanoid robot. Called Atlas, The Next Generation, the robot has capabilities like walking in snow, picking up objects, opening doors, and even helping itself up off the floor. Boston Dynamics writes that it's designed to operate outdoors and inside buildings.
Atlas Cables launches custom installation cable range at ISE 2016
Atlas Cables has announced the launch of two new installation-centric cable ranges dedicated to performance-led custom installations – Hyper si (Screened Installation) speaker cable and the Integra Duo analogue interconnect range. With the significant increase of wireless signals around any residential or commercial property, RF pollution is the scourge for all system designers and integrators.
Atlas robot learns how to do chores
Atlas, designed and operated by the Florida Institute for Human & Machine Cognition (IHMC), recently came second place at the DARPA Robotics Challenge, an annual competition that puts robots to the test in categories including stair climbing, door opening, rubble traversing and vehicle driving and dismounting. As you might have guessed, Atlas is good at practicing the same tasks over and over again.
Robotically driven system could reduce cost of drug discovery
Researchers from Carnegie Mellon University have created the first robotically driven experimentation system to determine the effects of a large number of drugs on many proteins, reducing the number of necessary experiments by 70%. The model, presented in the journal eLife, uses an approach that could lead to accurate predictions of the interactions between novel drugs and their targets, helping to reduce the cost of drug discovery.